Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harshal Bodke"'
Autor:
Dadasaheb Akolkar, Darshana Patil, Navin Srivastava, Revati Patil, Vineet Datta, Sachin Apurwa, Nitin Yashwante, Raja Dhasarathan, Rahul Gosavi, Jinumary John, Shabishta Khan, Ninad Jadhav, Priti Mene, Dhanashri Ahire, Sushant Pawar, Harshal Bodke, Subhraline Sahoo, Arun Nile, Dinesh Saindane, Harshal Darokar, Pradip Devhare, Ajay Srinivasan, Rajan Datar
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246048 (2021)
We present data on analytical validation of the multigene variant profiling assay (CellDx) to provide actionable indications for selection of targeted and immune checkpoint inhibitor (ICI) therapy in solid tumors. CellDx includes Next Generation Sequ
Externí odkaz:
https://doaj.org/article/14c1fdb7b51a495288351668340b7646
Autor:
S. Pawar, Rutuja Bhave, Raja Dhasarathan, Mahesh Ukade, Vineet Datta, Chirantan Bose, Harshal Bodke, Ajay Srinivasan, Stefan Schuster, Dadasaheb Akolkar, Shabista Khan, Cynthe Sims, Darshana Patil, Jatinder Bhatia, Vishakha Mhase, Sanket Patil, Rajan Datar, Sachin Apurwa, Samruddhi Raut
Publikováno v:
Cancer Research. 81:PS4-36
Background: Despite the development of Checkpoint Inhibitor Treatments (Immunotherapy) and Targeted anticancer agents, cytotoxic (chemotherapy) agents remain the mainstay of breast cancer treatments. However, treatment failure is often encountered in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f40c5256e99a56418ca3a337eb47941e
https://doi.org/10.1158/1538-7445.sabcs20-ps4-36
https://doi.org/10.1158/1538-7445.sabcs20-ps4-36
Autor:
Shoeb Patel, Stefan Schuster, Revati Patil, Pooja Fulmali, Raja Dhasarathan, Cynthe Sims, Shabista Khan, Darshana Patil, Harshal Bodke, Dadasaheb Akolkar, Vineet Datta, Archana Adhav, Rajan Datar, S. Pawar, Pradip Devhare, Pradip Fulmali, Sachin Apurwa, Ajay Srinivasan, Rohit A. Chougule, Sanket Patil, Vishal Ranjan, Jatinder Bhatia, Pradyumna Shejwalkar, Chirantan Bose
Publikováno v:
Cancer Research. 81:PS3-13
Background: Common modalities for breast cancer screening include self-breast examination (SBE) for detection of palpable lumps as well as Mammography scans for detection of suspicious nodules or masses. While both approaches have low specificity, SB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::886e0cc6f791a6f5e33ab405cf9597e2
https://doi.org/10.1158/1538-7445.sabcs20-ps3-13
https://doi.org/10.1158/1538-7445.sabcs20-ps3-13
Autor:
Dadasaheb Akolkar, Darshana Patil, Sneha Puranik, Swapnil Puranik, Pratiksha Sunil Nandre, Karishma Raosaheb Sabale, Sachin Apurwa, Harshal Bodke, Navin Shrivastava, Vineet Datta, Stefan Schuster, Jinumary John, Ajay Srinivasan, Rajan Datar
Real time monitoring of disease status is an essential part of cancer management. The low sensitivity and specificity of serum markers and the constraints and risks associated with radiological scans prompt the need for accurate non-invasive means to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58ec101dcc6713672890e2ac7547349b
https://doi.org/10.1101/2022.04.07.22273446
https://doi.org/10.1101/2022.04.07.22273446
Autor:
Raja Dhasarathan, Dadasaheb Akolkar, Arun Nile, Ninad Jadhav, Harshal Bodke, Darshana Patil, Pradip Devhare, Rahul Gosavi, Harshal Darokar, Dhanashri Ahire, Sachin Apurwa, Ajay Srinivasan, Vineet Datta, Subhraline Sahoo, Shabishta Khan, Revati Patil, Nitin Yashwante, Dinesh Saindane, S. Pawar, Jinumary John, Navin Srivastava, Priti Mene, Rajan Datar
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 2, p e0246048 (2021)
PLoS ONE, Vol 16, Iss 2, p e0246048 (2021)
We present data on analytical validation of the multigene variant profiling assay (CellDx) to provide actionable indications for selection of targeted and immune checkpoint inhibitor (ICI) therapy in solid tumors. CellDx includes Next Generation Sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::827f477bf394bd3e2eee6be526f451a0
http://europepmc.org/articles/PMC7870065
http://europepmc.org/articles/PMC7870065
Autor:
Sewanti Limaye, Rajan Datar, S. Pawar, Ashok Gawai, Darshana Patil, Cynthe Sims, Stefan Schuster, Tim Crook, Vineet Datta, Raymond L. Page, Ajay Srinivasan, Sachin Apurwa, Vishakha Mhase, Dadasaheb Akolkar, Harshal Bodke, Sanket Patil
Publikováno v:
Journal of Clinical Oncology. 38:3525-3525
3525 Background: Despite the development of targeted therapy agents and immune checkpoint inhibitors (ICI), cytotoxic anticancer agents remain the mainstay of treatment in several solid organ cancers. However, instances of innate and acquired resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::051c679b7e398ead692eda4921d00783
https://doi.org/10.1200/jco.2020.38.15_suppl.3525
https://doi.org/10.1200/jco.2020.38.15_suppl.3525